Anabolic Steroids Market Research Report with Forecast 2026 to 2035
Share With :
Anabolic Steroids Market Size is valued at USD 77.27 Bn in 2025 and is predicted to reach USD 195.30 Bn by the year 2035 at a 9.9% CAGR during the forecast period for 2026 to 2035.
Anabolic Steroids Market Size, Share & Trends Analysis Distribution by Compound Type (Oxandrolone, Testosterone, Stanozolol / Boldenone, Methyltestosterone, and Others), Route of Administration (Oral, Injectable, Transdermal Delivery Systems, and Others), End-user (Veterinary, Medical, Non-Medical, and Others), and Segment Forecasts, 2026 to 2035
Anabolic steroids are artificial forms of testosterone, a hormone involved in male sex. Among the derivatives of testosterone are norethandrolone, oxymetholone, and methyl testosterone. Because of their dual effects of boosting both male sexual traits (androgenic) and muscle building (anabolic), they are frequently referred to as anabolic-androgenic steroids (AAS). By boosting athletic performance or muscle mass, these substances increase looks. Anabolic steroids are occasionally recommended by doctors to treat ailments like insufficient testosterone, delayed puberty, or disease-related muscle loss. The growing prevalence of illnesses caused by a lack of testosterone is the main factor driving the expansion of the global anabolic steroids market. For older men, anabolic steroids are administered as part of testosterone replacement therapy to enhance their mood and sexual performance.
Moreover, muscular growth is inhibited by hypogonadism, or low testosterone levels. Young people's growing interest in bodybuilding and fitness is fueling the anabolic steroids market growth. Due to the growing popularity of fitness and the need to treat hypogonadism, or low testosterone levels, doctors are increasingly prescribing anabolic steroids to help people gain skeletal muscle. This is anticipated to accelerate market expansion over the course of the forecast period. Additionally, teenagers who experience delayed puberty may benefit from the medical usage of anabolic steroids. Furthermore, they aid in controlling the body's synthesis of cortisol, a hormone that is essential to the body's reaction to stress. In the upcoming years, it is anticipated that these variables would increase the use of anabolic steroids.
The increasing cost of healthcare, which contributes to the development of its infrastructure, is another important element impacting the anabolic steroids market. Additionally, various government agencies are working to enhance the healthcare system by increasing financing, which will have an even greater impact on market dynamics. In addition, pharmaceutical companies have a means to launch safer drugs due to the creation of novel drug delivery technologies and formulations that reduce adverse effects. The access to androgen treatments is expanded by the growing trend of telemedicine, which also creates new channels for prescription and consultation. However, the overuse and abuse of anabolic steroids, particularly in the context of sports and bodybuilding, is one of the main issues facing this market, though. Serious health hazards, such as liver damage, cardiovascular problems, and psychological disorders, may result from this.
• Pfizer Inc.
• Sun Pharmaceutical Industries
• Cipla LTA
• Hikma Pharmaceuticals
• Bayer AG
• AbbVie Inc.
• Teva Pharmaceutical Industries
• Ferring Pharmaceuticals
• Endo International
• Lupin LTA
• Zydus Lifesciences
• Perrigo Company
• Mylan
• Aspen Pharmacare
The rising popularity of bodybuilding among young people is one of the main factors propelling the anabolic steroids market. The performance-enhancing drug that is used worldwide is called steroids. The rise in athletic events has led to a significant growth in the demand for steroids, which is good for the worldwide steroid business. Steroids can promote the growth of facial and pubic hair. It deepens the voice in addition to increasing ambition and focus. Therefore, overly feminine hormones benefit from steroids. Additionally, the anabolic steroids market has grown as a result of more government initiatives to improve human services. The rise in male hypogonadism is anticipated to fuel the growth of the global anabolic steroid market. Moreover, it is anticipated that a rise in male impotence brought on by fatigue and weight issues will increase demand for anabolic steroids over the projection period.
The strict legal limits and regulatory framework enforced by governments around the world are a major barrier to the anabolic steroids market. Due to their potential for abuse, dependence, and major health risks—such as liver damage, cardiovascular diseases, psychological impacts, and reproductive complications—anabolic steroids are categorized as prohibited substances in many countries. As an example, the Anabolic Steroid Control Act in the United States restricts the production, distribution, and possession of anabolic steroids without a legitimate prescription by classifying them as Schedule III controlled substances. Further impeding market expansion are regulatory bodies like the World Anti-Doping Agency, which enforce stringent prohibitions on non-medical use in professional sports.
The Testosterone category held the largest share in the Anabolic Steroids market in 2025. The increasing usage of testosterone for the most acceptable medical applications is the reason for this growth. Healthcare professionals frequently prescribe testosterone to patients with acquired immunodeficiency syndrome (AIDS) or certain types of cancer in order to promote muscle growth and treat male hypogonadism, or low testosterone levels. The demand for testosterone is rising globally as a result of these advantages. Prominent market participants are concentrating on commercializing testosterone products in order to satisfy the heightened demand for these goods.
In 2025, the Injectable category dominated the Anabolic Steroids market. High unmet demand, an increase in bone and joint issues, government awareness campaigns for joint disorders, an increase in the number of obese people due to unhealthy lifestyles, and favorable health insurance coverage are some of the factors driving the injections market. According to the Statistic Brain Research Institute, 50 million people worldwide have been confirmed to have arthritis. Improved steroid injection treatment, rising health consciousness, and rising demand for steroid injections are some of the reasons propelling the global market for steroid injections. This market rise for anabolic steroids is being driven by the increasing demand for steroid injections due to their rapid and effective results.
The Anabolic Steroids market was dominated by North America region in 2025. The region has a strong need for testosterone replacement therapy and related treatments due to its sophisticated diagnostic infrastructure and high clinical knowledge of hormonal problems. The availability of regulated anabolic therapy for patients is improved by comprehensive insurance coverage and standardized endocrinologist practice guidelines. Partnerships between the U.S. Department of Veterans Affairs (VA) and private endocrine experts have improved older adult age-related testosterone deficiency screening and treatment programs. These programs have expanded patient populations and facilitated the production of empirical evidence that guides clinical practice. Additionally, there is still a lot of venture capital funding available for digital health platforms that concentrate on hormonal health, which is speeding up the use of remote monitoring tools.
| Report Attribute | Specifications |
| Market size value in 2025 | USD 77.27 Bn |
| Revenue forecast in 2035 | USD 195.30 Bn |
| Growth Rate CAGR | CAGR of 9.9% from 2026 to 2035 |
| Quantitative Units | Representation of revenue in US$ Bn and CAGR from 2026 to 2035 |
| Historic Year | 2022 to 2025 |
| Forecast Year | 2026-2035 |
| Report Coverage | The forecast of revenue, the position of the company, the competitive market structure, growth prospects, and trends |
| Segments Covered | Compound Type, Route of Administration, End-user, and By Region |
| Regional Scope | North America; Europe; Asia Pacific; Latin America; Middle East & Africa |
| Country Scope | U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; China; Japan; India; South Korea; Southeast Asia; South Korea; Southeast Asia |
| Competitive Landscape | Pfizer Inc., Sun Pharmaceutical Industries, Cipla LTA, Hikma Pharmaceuticals, Bayer AG, AbbVie Inc., Teva Pharmaceutical Industries, Ferring Pharmaceuticals, Endo International, Lupin LTA, Zydus Lifesciences, Perrigo Company, Mylan, and Aspen Pharmacare |
| Customization Scope | Free customization report with the procurement of the report, Modifications to the regional and segment scope. Geographic competitive landscape. |
| Pricing and Available Payment Methods | Explore pricing alternatives that are customized to your particular study requirements. |
• Oxandrolone
• Testosterone
• Stanozolol / Boldenone
• Methyltestosterone
• Others
• Oral
• Injectable
• Transdermal Delivery Systems
• Others
• Veterinary
• Medical
• Non-Medical
• Others
North America-
• The US
• Canada
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Mexico
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.